SANOFINSESanofi India Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 26 Feb · 15:41 IST

Sanofi India Limited has informed the Exchange about Copy of Newspaper Publication

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sanofi India Limited has submitted copies of the newspaper publication of its financial results for the quarter and year ended 31st December 2025. The results were published on 26th February 2026 in two newspapers — Business Standard (English) and Sakal (Marathi). This is a routine regulatory filing required under SEBI listing rules, which mandate companies to publish their quarterly/annual financial results in newspapers for public disclosure. The actual financial numbers are not included in this filing; the letter simply confirms the newspaper publication has been carried out and shared with BSE and NSE.

Likely market impact

This is a routine compliance filing with no direct impact on the stock price or shareholder value. It serves to inform the market that Sanofi India's Q3 FY26 and full-year FY25 results have been made publicly available through newspaper publication, ensuring wider investor access to the financial information.